Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study

Steroid‐refractory chronic graft‐vs‐host disease (cGvHD) contributes to morbidity after allogeneic hematopoietic stem cell transplantation. Here, we report on 11 patients with severe, refractory cGvHD treated with repeated infusions of allogeneic bone marrow‐derived mesenchymal stromal cells (MSC) o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cells Transl Med
Autors principals: Boberg, Erik, von Bahr, Lena, Afram, Gabriel, Lindström, Carina, Ljungman, Per, Heldring, Nina, Petzelbauer, Peter, Garming Legert, Karin, Kadri, Nadir, Le Blanc, Katarina
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Cell‐based Drug Development, Screening, and Toxicology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519760/
https://ncbi.nlm.nih.gov/pubmed/32573983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0099
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars